PATENT CLAIM ANALYSIS

Application Number: 15918195
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "210210"]

Abstract:
The present invention provides compounds of Formula (I): or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.

Claim (Index 10):
The compound of  claim 9  having Formula (VIII): or a stereoisomer, tautomer, pharmaceutically acceptable salt thereof, wherein:\n R 2  is selected from the group consisting of: H, F, CN, COMe, OH, OMe, OCHF 2 , CHF 2 , CF 3 , and tetrazole; \n R 3a  is selected from the group consisting of: H, F, Cl, CN, CO 2 H, \u2014CH 2 CO 2 H, CO 2 Me, \u2014CO 2 Et, \u2014CO 2 (i-Pr), \u2014CO 2 (t-Bu), \u2014CO 2 (n-Bu), \u2014CO 2 (i-Bu),\u2014and NHCO 2 Me; \n R 6  is selected from the group consisting of: H, Me, \u2014CO 2 Me, \u2014CO 2 (t-butyl), \u2014COMe, and \u2014CONHMe; \n q is 1 or 2; and \n r is 1 or 2.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 90.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14117513', '15361589', '14617979', '14886415', '14350411']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8628809849126522
- 35 USC 102 Novelty (BERT): 0.6574368905844464
- Combined Prediction Score: 0.8423365754798317
- Mean Citation Score: 542.883702
- Max Citation Score: 635.02765
- Similarity Product: 629.8148278615922

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test